ArticleTrials2021

Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.

Jill Hanass-Hancock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.